JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1351
Macy's
M
$5.85B
| $30.5M | ﹤0.01% |
1,476,394
+595,713
| +68% | +$12.2M |
2013 Q2
38 quarters
|
|
1352
PUT
Ford
F
$48.4B
| $30.4M | ﹤0.01% |
2,614,500
+536,900
| +26% | +$6.9M |
2015 Q3
29 quarters
|
|
1353
Skyworks Solutions
SWKS
$12.3B
| $30.3M | ﹤0.01% |
333,035
+110,803
| +50% | +$9.93M |
2013 Q2
38 quarters
|
|
1354
SS&C Technologies
SSNC
$18.6B
| $30.3M | ﹤0.01% |
582,059
-134,719
| -19% | -$6.83M |
2015 Q3
29 quarters
|
|
1355
PUT
Humana
HUM
$47.1B
| $30.1M | ﹤0.01% |
58,700
+44,400
| +310% | +$23.3M |
2020 Q4
8 quarters
|
|
|
PDCE
1356
DELISTED
PDC Energy, Inc.
PDCE
| $30M | ﹤0.01% |
473,269
+4,422
| +0.9% | +$308K |
2013 Q2
38 quarters
|
|
1357
CALL
Walmart Inc
WMT
$830B
| $30M | ﹤0.01% |
635,100
+306,300
| +93% | +$14.5M |
2016 Q2
26 quarters
|
|
|
NSTC
1358
DELISTED
Northern Star Investment Corp. III
NSTC
| $30M | ﹤0.01% |
+2,983,670
| New | +$29.7M |
2022 Q4
0 quarters
|
|
1359
Popular Inc
BPOP
$10.1B
| $29.9M | ﹤0.01% |
450,647
-5,057
| -1% | -$352K |
2013 Q2
38 quarters
|
|
1360
Tanger
SKT
$4.02B
| $29.8M | ﹤0.01% |
1,662,003
+1,223,291
| +279% | +$22M |
2013 Q2
38 quarters
|
|
|
ANSS
1361
DELISTED
Ansys
ANSS
| $29.8M | ﹤0.01% |
123,350
+7,817
| +7% | +$1.82M |
2013 Q2
38 quarters
|
|
|
P
1362
PUT
Everpure Inc
P
$47B
| $29.8M | ﹤0.01% |
1,112,400
+732,400
| +193% | +$21.3M |
2022 Q2
2 quarters
|
|
1363
Charles River Laboratories
CRL
$14.6B
| $29.8M | ﹤0.01% |
136,600
-2,964
| -2% | -$647K |
2013 Q2
38 quarters
|
|
1364
Alerian MLP ETF
AMLP
$13B
| $29.7M | ﹤0.01% |
780,220
-271,117
| -26% | -$10.7M |
2013 Q2
38 quarters
|
|
1365
UGI
UGI
$7.92B
| $29.6M | ﹤0.01% |
798,017
-195,586
| -20% | -$7.07M |
2013 Q2
38 quarters
|
|
1366
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.8B
| $29.5M | ﹤0.01% |
217,300
+200,000
| +1,156% | +$26.5M |
2021 Q3
5 quarters
|
|
1367
CALL
Biogen
BIIB
$32.3B
| $29.4M | ﹤0.01% |
106,300
-145,400
| -58% | -$41.1M |
2021 Q3
5 quarters
|
|
1368
Diageo
DEO
$46.4B
| $29.4M | ﹤0.01% |
164,870
+3,726
| +2% | +$654K |
2013 Q2
38 quarters
|
|
1369
Invesco Senior Loan ETF
BKLN
$6.49B
| $29.3M | ﹤0.01% |
1,428,825
+1,171,023
| +454% | +$24.3M |
2013 Q2
38 quarters
|
|
|
PCH
1370
DELISTED
PotlatchDeltic
PCH
| $29.3M | ﹤0.01% |
666,153
+128,573
| +24% | +$5.82M |
2013 Q2
38 quarters
|
|
1371
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.54B
| $29.3M | ﹤0.01% |
290,566
+10,043
| +4% | +$1M |
2013 Q2
38 quarters
|
|
1372
Petrobras
PBR
$158B
| $29.1M | ﹤0.01% |
2,735,489
-1,819,240
| -40% | -$22M |
2013 Q2
38 quarters
|
|
1373
SiriusXM
SIRI
$8.78B
| $29.1M | ﹤0.01% |
498,573
+86
| +0% | +$5.29K |
2013 Q2
38 quarters
|
|
1374
Central Garden & Pet Co Class A
CENTA
$2.15B
| $29.1M | ﹤0.01% |
1,014,855
+268,310
| +36% | +$8.06M |
2013 Q2
38 quarters
|
|
1375
BILL Holdings
BILL
$3.75B
| $29M | ﹤0.01% |
266,487
+8,239
| +3% | +$989K |
2019 Q4
12 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.